JP2018520124A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018520124A5 JP2018520124A5 JP2017563973A JP2017563973A JP2018520124A5 JP 2018520124 A5 JP2018520124 A5 JP 2018520124A5 JP 2017563973 A JP2017563973 A JP 2017563973A JP 2017563973 A JP2017563973 A JP 2017563973A JP 2018520124 A5 JP2018520124 A5 JP 2018520124A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- heterocycloalkyl
- alkylene
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562185203P | 2015-06-26 | 2015-06-26 | |
| US62/185,203 | 2015-06-26 | ||
| PCT/US2016/039270 WO2016210275A1 (en) | 2015-06-26 | 2016-06-24 | Treatment of nut midline carcinoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018520124A JP2018520124A (ja) | 2018-07-26 |
| JP2018520124A5 true JP2018520124A5 (enExample) | 2019-07-25 |
Family
ID=56409188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017563973A Pending JP2018520124A (ja) | 2015-06-26 | 2016-06-24 | Ｎｕｔ正中線癌の治療 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20180193350A1 (enExample) |
| EP (1) | EP3314005A1 (enExample) |
| JP (1) | JP2018520124A (enExample) |
| KR (1) | KR20180035785A (enExample) |
| CN (1) | CN107787227A (enExample) |
| AR (1) | AR105124A1 (enExample) |
| AU (1) | AU2016283020A1 (enExample) |
| BR (1) | BR112017028178A2 (enExample) |
| CA (1) | CA2989313A1 (enExample) |
| HK (1) | HK1252062A1 (enExample) |
| IL (1) | IL256186A (enExample) |
| MA (1) | MA42249A (enExample) |
| MX (1) | MX2017016337A (enExample) |
| WO (1) | WO2016210275A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8981083B2 (en) | 2010-05-14 | 2015-03-17 | Dana Farber Cancer Institute, Inc. | Compositions and methods for treating neoplasia, inflammatory disease and other disorders |
| MX373121B (es) | 2010-05-14 | 2020-04-30 | Dana Farber Cancer Inst Inc | Composiciones y metodos para el tratamiento de leucemia. |
| KR20160072261A (ko) | 2013-11-08 | 2016-06-22 | 다나-파버 캔서 인스티튜트 인크. | 브로모도메인 및 엑스트라-말단 (bet) 단백질 저해제를 이용한 암 치료를 위한 조합 요법 |
| RU2722179C2 (ru) | 2014-02-28 | 2020-05-28 | Тэнша Терапеутикс, Инк. | Лечение состояний, ассоциированных с гиперинсулинемией |
| UA122130C2 (uk) | 2014-10-27 | 2020-09-25 | Тенша Терапеутікс, Інк. | Інгібітори бромодомену |
| EP4629984A1 (en) * | 2022-12-06 | 2025-10-15 | BioVentures, LLC | Development of potent dual hdac/brd4 inhibitors |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| EP2239264A4 (en) * | 2007-12-28 | 2012-01-11 | Mitsubishi Tanabe Pharma Corp | ANTITUMORAL MEDIUM |
| GB0919431D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| KR20120097508A (ko) | 2009-11-05 | 2012-09-04 | 글락소스미스클라인 엘엘씨 | 벤조디아제핀 브로모도메인 억제제 |
| GB0919432D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Use |
| GB0919423D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| MY160456A (en) | 2009-11-05 | 2017-03-15 | Glaxosmithkline Llc | Benzodiazepine bromodomain inhibitor |
| GB0919434D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| GB0919426D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| US8981083B2 (en) | 2010-05-14 | 2015-03-17 | Dana Farber Cancer Institute, Inc. | Compositions and methods for treating neoplasia, inflammatory disease and other disorders |
| JP5715241B2 (ja) * | 2010-05-14 | 2015-05-07 | ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド | 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法 |
| US9085582B2 (en) | 2010-06-22 | 2015-07-21 | Glaxosmithkline Llc | Benzotriazolodiazepine compounds inhibitors of bromodomains |
| US9249161B2 (en) | 2010-12-02 | 2016-02-02 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| AR084070A1 (es) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| WO2012151512A2 (en) | 2011-05-04 | 2012-11-08 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| US9328117B2 (en) | 2011-06-17 | 2016-05-03 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| TWI602820B (zh) | 2012-06-06 | 2017-10-21 | 星宿藥物公司 | 溴域抑制劑及其用途 |
| RU2722179C2 (ru) | 2014-02-28 | 2020-05-28 | Тэнша Терапеутикс, Инк. | Лечение состояний, ассоциированных с гиперинсулинемией |
-
2016
- 2016-06-24 AU AU2016283020A patent/AU2016283020A1/en not_active Abandoned
- 2016-06-24 MA MA042249A patent/MA42249A/fr unknown
- 2016-06-24 EP EP16738292.8A patent/EP3314005A1/en not_active Withdrawn
- 2016-06-24 CA CA2989313A patent/CA2989313A1/en not_active Abandoned
- 2016-06-24 BR BR112017028178-3A patent/BR112017028178A2/en not_active Application Discontinuation
- 2016-06-24 WO PCT/US2016/039270 patent/WO2016210275A1/en not_active Ceased
- 2016-06-24 CN CN201680036201.4A patent/CN107787227A/zh active Pending
- 2016-06-24 AR ARP160101908A patent/AR105124A1/es unknown
- 2016-06-24 MX MX2017016337A patent/MX2017016337A/es unknown
- 2016-06-24 KR KR1020187000569A patent/KR20180035785A/ko not_active Withdrawn
- 2016-06-24 HK HK18111394.9A patent/HK1252062A1/zh unknown
- 2016-06-24 US US15/739,905 patent/US20180193350A1/en not_active Abandoned
- 2016-06-24 JP JP2017563973A patent/JP2018520124A/ja active Pending
-
2017
- 2017-12-07 IL IL256186A patent/IL256186A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018520124A5 (enExample) | ||
| JP2017515856A5 (enExample) | ||
| JP2017121233A5 (enExample) | ||
| JP2019522055A5 (enExample) | ||
| JP2015532295A5 (enExample) | ||
| JP2017521387A5 (enExample) | ||
| RU2016147742A (ru) | Дейтрированные гетероциклические соединения и их применение в качестве средств визуализации | |
| RU2019100164A (ru) | Гетероциклическое соединение, используемое как ингибитор fgfr | |
| JP2017530984A5 (enExample) | ||
| JP2019537570A5 (enExample) | ||
| JP2016509047A5 (enExample) | ||
| JP2009528271A5 (enExample) | ||
| JP2011517683A5 (enExample) | ||
| JP2017537080A5 (enExample) | ||
| JP2019505529A5 (enExample) | ||
| JP2016503797A5 (enExample) | ||
| JP2013544846A5 (enExample) | ||
| JP2017508789A5 (enExample) | ||
| RU2014135436A (ru) | Комбинация ингибитора rtk с антиэстрогеном и ее применение для лечения рака | |
| JP2013521233A5 (enExample) | ||
| JP2016513661A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| JP2014513065A5 (enExample) | ||
| JP2019516739A5 (enExample) | ||
| JP2016531871A5 (enExample) |